Abstract:We sought to develop and validate machine learning (ML) models to increase the predictive accuracy of mortality after heart transplantation (HT).
Methods and results:We included adult HT recipients from the United Network for Organ Sharing (UNOS) database between 2010 and 2018 using solely pre-transplant variables. The study cohort comprised 18 625 patients (53 ± 13 years, 73% males) and was randomly split into a derivation and a validation cohort with a 3:1 ratio. At 1-year after HT, there were 2334 (12.5%) d… Show more
“…Moreover, recent research also strives to make ML models more interpretable in terms of identifying features playing a key role during the prediction tasks. Some recent methods including SHapley Additive exPlanations (SHAP) as used for evaluating feature importance and explain the predictions made by ML algorithms toward post-LT AKI 57 , Local Interpretable Model-Agnostic Explanations (LIME) used to assess relative impact of key predictors in post-transplant patient survival 58 , and integrated gradients used to identify important predictors in diagnosing allograft rejection 59 , make ML models more explainable. However, further validation of their results using multicenter prospectively collected data is important before wider application of these algorithms in daily clinical practice.…”
Solid-organ transplantation is a life-saving treatment for end-stage organ disease in highly selected patients. Alongside the tremendous progress in the last several decades, new challenges have emerged. The growing disparity between organ demand and supply requires optimal patient/donor selection and matching. Improvements in long-term graft and patient survival require data-driven diagnosis and management of post-transplant complications. The growing abundance of clinical, genetic, radiologic, and metabolic data in transplantation has led to increasing interest in applying machine-learning (ML) tools that can uncover hidden patterns in large datasets. ML algorithms have been applied in predictive modeling of waitlist mortality, donor–recipient matching, survival prediction, post-transplant complications diagnosis, and prediction, aiming to optimize immunosuppression and management. In this review, we provide insight into the various applications of ML in transplant medicine, why these were used to evaluate a specific clinical question, and the potential of ML to transform the care of transplant recipients. 36 articles were selected after a comprehensive search of the following databases: Ovid MEDLINE; Ovid MEDLINE Epub Ahead of Print and In-Process & Other Non-Indexed Citations; Ovid Embase; Cochrane Database of Systematic Reviews (Ovid); and Cochrane Central Register of Controlled Trials (Ovid). In summary, these studies showed that ML techniques hold great potential to improve the outcome of transplant recipients. Future work is required to improve the interpretability of these algorithms, ensure generalizability through larger-scale external validation, and establishment of infrastructure to permit clinical integration.
“…Moreover, recent research also strives to make ML models more interpretable in terms of identifying features playing a key role during the prediction tasks. Some recent methods including SHapley Additive exPlanations (SHAP) as used for evaluating feature importance and explain the predictions made by ML algorithms toward post-LT AKI 57 , Local Interpretable Model-Agnostic Explanations (LIME) used to assess relative impact of key predictors in post-transplant patient survival 58 , and integrated gradients used to identify important predictors in diagnosing allograft rejection 59 , make ML models more explainable. However, further validation of their results using multicenter prospectively collected data is important before wider application of these algorithms in daily clinical practice.…”
Solid-organ transplantation is a life-saving treatment for end-stage organ disease in highly selected patients. Alongside the tremendous progress in the last several decades, new challenges have emerged. The growing disparity between organ demand and supply requires optimal patient/donor selection and matching. Improvements in long-term graft and patient survival require data-driven diagnosis and management of post-transplant complications. The growing abundance of clinical, genetic, radiologic, and metabolic data in transplantation has led to increasing interest in applying machine-learning (ML) tools that can uncover hidden patterns in large datasets. ML algorithms have been applied in predictive modeling of waitlist mortality, donor–recipient matching, survival prediction, post-transplant complications diagnosis, and prediction, aiming to optimize immunosuppression and management. In this review, we provide insight into the various applications of ML in transplant medicine, why these were used to evaluate a specific clinical question, and the potential of ML to transform the care of transplant recipients. 36 articles were selected after a comprehensive search of the following databases: Ovid MEDLINE; Ovid MEDLINE Epub Ahead of Print and In-Process & Other Non-Indexed Citations; Ovid Embase; Cochrane Database of Systematic Reviews (Ovid); and Cochrane Central Register of Controlled Trials (Ovid). In summary, these studies showed that ML techniques hold great potential to improve the outcome of transplant recipients. Future work is required to improve the interpretability of these algorithms, ensure generalizability through larger-scale external validation, and establishment of infrastructure to permit clinical integration.
“…The classification performance of the competing ML models was evaluated with respect to a number of evaluation criteria that are extracted on the basis of the confusion matrix. Specifically, precision, sensitivity, specificity and classification accuracy have been widely utilized in the recent literature to assess the predictive performance of ML techniques in various health applications [45][46][47][48]. The aforementioned metrics are shortly described below.…”
CrossFit has gained recognition and interest among physically active populations being one of the most popular and rapidly growing exercise regimens worldwide. Due to the intense and repetitive nature of CrossFit, concerns have been raised over the potential injury risks that are associated with its training including rhabdomyolysis and musculoskeletal injuries. However, identification of risk factors for predicting injuries in CrossFit athletes has been limited by the absence of relevant big epidemiological studies. The main purpose of this paper is the identification of risk factors and the development of machine learning-based models using ensemble learning that can predict CrossFit injuries. To accomplish the aforementioned targets, a survey-based epidemiological study was conducted in Greece to collect data on musculoskeletal injuries in CrossFit practitioners. A Machine Learning (ML) pipeline was then implemented that involved data pre-processing, feature selection and well-known ML models. The performance of the proposed ML models was assessed using a comprehensive cross validation mechanism whereas a discussion on the nature of the selected features is also provided. An area under the curve (AUC) of 77.93% was achieved by the best ML model using ensemble learning (Adaboost) on the group of six selected risk factors. The effectiveness of the proposed approach was evaluated in a comparative analysis with respect to numerous performance metrics including accuracy, sensitivity, specificity, AUC and confusion matrices to confirm its clinical relevance. The results are the basis for the development of reliable tools for the prediction of injuries in CrossFit.
“…The most well recognized are the Seattle Heart Failure Model (SHFM), the Heart Failure Survival Score (HFSS), and the Interagency Registry for Mechanically Assisted Circulatory Support (INTER-MACS) [4,30]. The application of machine learning to clinical registry to predict posttransplant outcomes is an active area of research [31].…”
Purpose of reviewHeart failure incidence continues to rise despite a relatively static number of available donor hearts. Selecting an appropriate heart transplant candidate requires evaluation of numerous factors to balance patient benefit while maximizing the utility of scarce donor hearts. Recent research has provided new insights into refining recipient risk assessment, providing additional tools to further define and balance risk when considering heart transplantation.
Recent findingsRecent publications have developed models to assist in risk stratifying potential heart transplant recipients based on cardiac and noncardiac factors. These studies provide additional tools to assist clinicians in balancing individual risk and benefit of heart transplantation in the context of a limited donor organ supply.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.